Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Data Format

<< Previous

Bullboard Posts

Next >>

Comment by Donein25on Apr 27, 2023 4:44pm

166 Views

Post# 35417969

RE:RE:New Data Format

CS. The KM curve shows us at 28% for 450 day CR. You are correct that it excludes the first 12 undertreated and the 3 patients from Phase 1. But if you go back to the November #s, which did include the 12 undertreated and the 3 patients from Phase 1, we are also at the same 450 day CR of 28%. Same % (28) with seemingly different patient pools. Am I wrong on this? Are we seeing a demonstrated efficacy %?

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale